Skip to main content

Torsades de Pointes After Methadone Treatment

  • Chapter
  • First Online:
Challenging Cases and Complication Management in Pain Medicine
  • 1089 Accesses

Abstract

Methadone is a synthetic opioid used to treat chronic pain and for maintenance therapy in opiate dependence. Methadone may cause QT prolongation and torsades de pointes, an arrhythmia. Several risk factors predispose patients to the development of this potentially fatal arrhythmia. Careful patient selection, mitigating risk factors, and regular monitoring are recommended to prescribers of methadone. With the increased number of methadone-related deaths, more research is needed to bridge informational gaps regarding its safety.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Caplehorn JR, Dalton MS, Haldar F, Petrenas AM, Nisbet JG. Methadone maintenance and addicts’ risk of fatal heroin overdose. Subst Use Misuse. 1996;31:177–96.

    Article  CAS  PubMed  Google Scholar 

  2. Gronbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand. 1990;82:223–7.

    Article  CAS  PubMed  Google Scholar 

  3. National Institutes of Health: NIH consensus panel recommends expanding access to and improving methadone treatment programs for heroin addiction. Eur Addict Res. 1999;5:50–1.

    Google Scholar 

  4. Chou R, Weimer MB, Dana T. Methadone overdose and cardiac arrhythmia potential: findings from a review of the evidence for an American Pain Society and College on Problems of Drug Dependence clinical practice guideline. J Pain. 2014;15:338–65.

    Article  CAS  PubMed  Google Scholar 

  5. Chou R. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manag. 2004;26:1026.

    Article  Google Scholar 

  6. General Accountability Office: Methadone-associated overdose deaths: factors contributing to increased deaths and efforts to prevent them. http://www.gao.gov/products/GAO-09-341. Accessed 16 Nov 2015.

  7. Lynch ME. A review of the use of methadone for the treatment of chronic noncancer pain. Pain Res Manag. 2005;10:133–44.

    Article  PubMed  Google Scholar 

  8. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain. 2002;18:S3–S13.

    Article  PubMed  Google Scholar 

  9. Anderson R, Saiers JH, Abram S, Schlicht C. Accuracy in equianalgesic dosing: conversion dilemmas. J Pain Symptom Manag. 2001;21:397–406.

    Article  CAS  Google Scholar 

  10. Christie JM. Opioid prescribing: methadone risk mitigation. Anesthesia Patient Safety Foundation Newsletter. 2011;26:1–15.

    Google Scholar 

  11. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Torsades de pointes associated with very-high-dose methadone. Ann Intern Med. 2002;137:501–4.

    Article  CAS  PubMed  Google Scholar 

  12. Fanoe S, Hvidt C, Ege P, Jensen GB. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart. 2007;93:1051–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Cruciani RA, Sekine R, Homel P, et al. Measurement of QTc in patients receiving chronic methadone therapy. J Pain Symptom Manag. 2005;29:385–91.

    Article  CAS  Google Scholar 

  14. Chang KC, Huang CL, Liang HY, et al. Gender-specific differences in susceptibility to low dose methadone-associated QTc prolongation in patients with heroin dependence. J Cardiovasc Electrophysiol. 2012;23:527–33.

    Article  PubMed  Google Scholar 

  15. Athanasos P, Farquharson AL, Compton P, Psaltis P, Hay J. Electrocardiogram characteristics of methadone and buprenorphine maintained subjects. J Addict Dis. 2008;27:31–5.

    Article  PubMed  Google Scholar 

  16. Fareed A, Vayalapalli S, Byrd-Sellers J, et al. Onsite QTc interval screening for patients in methadone maintenance treatment. J Addict Dis. 2010;29:15–22.

    Article  PubMed  Google Scholar 

  17. Maremmani I, Pacini M, Cesaroni C, Lovrecic M, Perugi G, Tagliamonte A. QTc interval prolongation in patients on long-term methadone maintenance therapy. Eur Addict Res. 2005;11:44–9.

    Article  PubMed  Google Scholar 

  18. Mayet S, Gossop M, Lintzeris N, Markides V, Strang J. Methadone maintenance, QTc and torsades de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug Alcohol Rev. 2011;30:388–96.

    Article  PubMed  Google Scholar 

  19. Katz DF, Sun J, Khatri V, et al. QTc interval screening in an opioid treatment program. Am J Cardiol. 2013;112:1013–8.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Peles E, Bodner G, Kreek MJ, Rados V, Adelson M. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. Addiction. 2007;102:289–300.

    Article  PubMed  Google Scholar 

  21. Roy AK, McCarthy C, Kiernan G, et al. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy. Addiction. 2012;107:1132–9.

    Article  PubMed  Google Scholar 

  22. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Dose-related effects of methadone on QT prolongation in a series of patients with torsades de pointes. Pharmacotherapy. 2003;23:802–5.

    Article  CAS  PubMed  Google Scholar 

  23. Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN. Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol. 2005;95:915–8.

    Article  CAS  PubMed  Google Scholar 

  24. Justo D, Gal-Oz A, Paran Y, Goldin Y, Zeltser D. Methadone-associated torsades de pointes (polymorphic ventricular tachycardia) in opioid-dependent patients. Addiction. 2006;101:1333–8.

    Article  PubMed  Google Scholar 

  25. Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction. 2009;104:993–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Shashoua .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Shashoua, A. (2018). Torsades de Pointes After Methadone Treatment. In: Anitescu, M., Benzon, H., Wallace, M. (eds) Challenging Cases and Complication Management in Pain Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-60072-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-60072-7_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-60070-3

  • Online ISBN: 978-3-319-60072-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics